Micronesia (country) vs United Arab Emirates: The number of people with susceptibility test result for rifampicin
Micronesia (country)
27
in 2021
United Arab Emirates
23
in 2021
Micronesia (country) rank
129th
United Arab Emirates rank
131st
The number of people with susceptibility test result for rifampicin over time
- Micronesia (country)
- United Arab Emirates
How they compare
Micronesia (country) currently reports 27 against 23 in United Arab Emirates, a difference of 4.
That makes Micronesia (country)'s figure about 1.2 times United Arab Emirates's.
The two have swapped places 4 times across 5 shared years of data; in 2017 it was Micronesia (country) ahead.
Micronesia (country) ranks 129th and United Arab Emirates ranks 131st of 155 countries.
Micronesia (country) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Micronesia (country) | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 32 | 32 | 0 | — |
| 2020s | 28 | 26 | 2 | Micronesia (country) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Micronesia (country) or United Arab Emirates?
- Micronesia (country), at 27 against 23 in United Arab Emirates as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Micronesia (country) and United Arab Emirates?
- 4, with Micronesia (country) ahead.
- How many years of comparable data are there for Micronesia (country) and United Arab Emirates?
- 5 years are reported by both, from 2017 to 2021.
- How do Micronesia (country) and United Arab Emirates rank globally for the number of people with susceptibility test result for rifampicin?
- Micronesia (country) ranks 129th and United Arab Emirates ranks 131st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.